The epidemiology of multiple sclerosis: A general overview

Annals of Neurology

Volumn 36, Issue 2 S, 1994, Pages S180-S193

  Poser, Charles M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; MIGRATION; MULTIPLE SCLEROSIS; NEW ZEALAND; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR;

BRAIN; CLUSTER ANALYSIS; DISEASE OUTBREAKS; GENETIC PREDISPOSITION TO DISEASE; HUMAN; INCIDENCE; MULTIPLE SCLEROSIS; PREVALENCE; RISK FACTORS;

EID: 0028110427     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410360805     Document Type: Article

References (98)

1. New diagnostic criteria for multiple sclerosis
2. Clinical picture of MS in Asia
3. Prognosis in acute disseminated encephalomyelitis with a note on neuromyelitis optica
4. Taxonomy and diagnostic parameters
5. Oligodendrocyte injury is an early event in lesions of multiple sclerosis
6. The unfortunate triumph of mechanodiagnosis: a clinician's lament
7. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis
8. Impact of magnetic resonance imaging (MRI) on the epidemiology of MS
9. Multiple sclerosis: from the standpoint of geographic distribution and race
10. Incidence of multiple sclerosis in United States troops
11. Multiple sclerosis. I. The etiological significance of the regional and occupational incidence
12. Geographic distribution of multiple sclerosis
13. The epidemiology of MS in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians
14. MS is prevalent in the Zoroastrians (Parsis) of India
15. Descriptive and analytical epidemiological data on multiple sclerosis from a long‐term study in Southern Hesse, Germany
16. The epidemiology of multiple sclerosis in Uzbekistan
17. MS in Hungary, including the Gypsy population
18. The changing frequency of MS in Israel
19. Newer study fails to support environmental factor in etiology of MS
20. MS in the Negro
21. Racial admixture in US blacks
22. Multiple sclerosis: observations and reflections—a personal memoir
23. MS in Iraq: a clinical and geomedical survey
24. The geography of MS reflects genetic susceptibility
25. Prevalence of multiple sclerosis
26. Multiple sclerosis in twins
27. Epidemiology of multiple sclerosis in US veterans: V. Ancestry and the risk of multiple sclerosis
28. La sclérose en plaques dans la race noire
29. Prevalence of MS and North‐South gradient in Japan
30. MS in Taiwan—a reappraisal
31. Prevalence of multiple sclerosis: a door‐to‐door survey in Lan Cang La Hu Zu Autonomous County, Yunnan Province of China
32. Multiple sclerosis among Chinese in Hong Kong
33. Epidemiology of multiple sclerosis in Australia
34. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
35. Risk factors for multiple sclerosis: race or place?
36. Occurrence of multiple sclerosis in the north and south of New Zealand
37. The epidemiology of multiple sclerosis. The Iceland model
38. Multiple sclerosis in Iceland: 1900–1985
39. Prevalence of multiple sclerosis in North East Scotland
40. A further prevalence study of multiple sclerosis in North East Scotland
41. The Chief Scientist reports….: multiple sclerosis in North East Scotland
42. Multiple sclerosis in Olmsted and Mower Counties, Minnesota
43. Impairment, disability, and handicap in multiple sclerosis
44. Prevalence, incidence and characteristics of multiple sclerosis in Westlock Country, Alberta, Canada
45. Multiple sclerosis: an epidemic disease in the Faroes
46. Multiple sclerosis in Iceland. I. Evidence of a postwar epidemic
47. Multiple sclerosis in the Faroes: epidemic IV
48. An analysis of the “epidemic” of MS in the Faroe Islands. I. Clinical and epidemiological aspects
49. An analysis of the “epidemic” of MS in the Faroe Islands. II. Biostatistical aspects
50. A new multiple sclerosis epidemic?
51. Multiple sclerosis epidemic in Kenya?
52. Incidence of MS in Macomer, Sardinia, 1912–1981
53. Multiple sclerosis in a small New England community
54. Multiple sclerosis clustering in a small Massachusetts community, with possible common exposure 23 years before onset
55. Multiple sclerosis: a cluster in a small northwestern United States community
56. Unusual occurrence on a tropical island of multiple sclerosis
57. Multiple sclerosis in Key West, Florida
58. Multiple sclerosis on islands
59. Multiple sclerosis in islands
60. Increasing prevalence of multiple sclerosis in Malta: 1978 to 1988
61. Risk of multiple sclerosis related to age at immigration
62. On the risk of multiple sclerosis according to age at immigration to South Africa
63. Multiple sclerosis and age at migration
64. Evidence for lower susceptibility to multiple sclerosis among Japanese‐Americans
65. Multiple sclerosis in a migrant population. 2. Half‐Orientals immigrating in childhood
66. Multiple sclerosis among immigrants in Greater London
67. Multiple sclerosis among the United Kingdom‐born children of immigrants from the Indian subcontinent, Africa and the West Indies
68. La sclérose en plaques en Afrique, au sud du Sahar
69. Annual incidence, prevalence, and mortality of multiple sclerosis in white South African born and in white immigrants to South Africa
70. MS among Orientals and Caucasians in Hawaii
71. Correlation analysis between bovine populations, other farm animals, house pets, and multiple sclerosis prevalence
72. The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor‐analytic study
73. Trauma and multiple sclerosis
74. Analytic, experimental and theoretical epidemiology
75. Scrapie and kuru
76. A population‐based study of MS twins
77. HLA haplotypes in families with high frequency of multiple sclerosis
78. Virus antibody titers in MS patients, siblings and controls
79. Virus antibodies in serum specimens from patients with MS. from siblings, and matched controls. A final report
80. Viral antibodies in twins with MS
81. Viral antibodies in MS: a nationwide co‐twin study
82. Genetic and immunological case studies in familial MS
83. Lymphocyte activation in discordant twin pairs
84. Oligoclonal bands in CSF: twins with MS
85. Correlation of oligoclonal IgG bands and viral antibodies in twins with multiple sclerosis
86. Familial subclinical MS
87. Inflammatory vasculitis in MS
88. Blood‐brain barrier damage in acute MS plaques
89. Epidemiologic evidence for multiple sclerosis as an infection
90. Magnetic resonance imaging in asymptomatic disseminated vasculomyelopathy